Pfizer and BioNTech will test an omicron-specific COVID-19 vaccine in adult trials
Pfizer and BioNTech will conduct three simultaneous trials in adults to determine if an omicron-specific vaccine is more effective than current shots.
Pfizer and BioNTech will test an omicron-specific COVID-19 vaccine in adult trials
USATODAY.com
0 shares
1 views
You might like
Related news coverage
Why Novavax Stock Is Sinking Again This Week
Motley Fool
Investors appear to be concerned about Pfizer's and BioNTech's head start in developing an omicron-specific vaccine.
-
Pfizer, BioNTech start clinical trial of Omicron-specific Covid-19 vaccine
newKerala.com
-
Pfizer-BioNTech begin clinical trials of Covid-19 vaccine specific to Omicron variant
DNA
-
Pfizer Human Trials for Omicron-Specific COVID-19 Vaccine Begins: Full Details
HNGN
-
The latest on the coronavirus pandemic and the Omicron variant
Upworthy
Advertisement
More coverage
Pfizer And BioNtech Begin Clinical Trial For Omicron-Specific COVID-19 Vaccine
cbs4.com
Pfizer and BioNTech have started a clinical trial for their Omicron-specific COVID-19 vaccine.
-
Pfizer-BioNTech initiate study on updated Omicron-specific vaccine shots
DNA
-
Pfizer and BioNTech announce trials of new Omicron jab
BBC News
-
Pfizer and BioNTech start trials of new Omicron-specific jab
BBC News
-
Coronavirus Update: Pfizer and BioNTech launch study of omicron-specific vaccine
MarketWatch